SCHEMBL640718

SCHEMBL640718

CC(C)C(CCN)C(C)C

nearest known ligand 0.39

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
GABRR1 P24046 2/20 0.39
GABBR2 O75899 2/20 0.38
GABBR1 Q9UBS5 2/20 0.38
ALDH1A1 P00352 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL640973 0.80 NFKB1 (0.35) ALDH1A1
SCHEMBL18965474 0.80 GABRR1 (0.32) GABRR1GABBR2GABBR1
SCHEMBL504336 0.78 NFKB1 (0.41) ALDH1A1
SCHEMBL23121502 0.76 GABRR1 (0.38) GABRR1GABBR2GABBR1ALDH1A1
SCHEMBL9420958 0.74 ALDH1A1 (0.53) GABRR1GABBR2GABBR1ALDH1A1
SCHEMBL60727 0.74
SCHEMBL14498560 0.74
SCHEMBL6687775 0.74
SCHEMBL565763 0.73 GABRR1 (0.42) GABRR1GABBR2GABBR1ALDH1A1
SCHEMBL23194400 0.72 METAP1 (0.31) GABRR1GABBR2GABBR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 125 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115286657-A Continuous production method of hydroxymethyl phosphonate 湖北理工学院 2022-11-04 CN claimed
CN-112981540-B Diisopropylpropylamine tetrafluoroborate crystal material and preparation method and application thereof 江苏建筑职业技术学院 2022-02-01 CN claimed
CN-112981540-A Diisopropylpropylamine tetrafluoroborate crystal material and preparation method and application thereof 江苏建筑职业技术学院 2021-06-18 CN claimed
CN-112538025-A Preparation method of fluorine-containing compound for hydrophobic surface treatment agent 湖北福力德鞋业有限责任公司 2021-03-23 CN claimed
US-9187504-B2 Method of making hydroxymethylphosphonate ICL-IP AMERICA INC. (US) 2015-11-17 US claimed
EP-2376507-B1 METHOD OF MAKING HYDROXYMETHYLPHOSPHONATES ICL IP AMERICA INC (US) 2013-05-15 EP claimed
US-8198341-B2 Method of making hydroxymethylphosphonate, polyurethane foam-forming compositions, polyurethane foam and articles made therefrom ICL-IP AMERICA INC. (US) 2012-06-12 US claimed
US-20110257287-A1 Method of Making Hydroxymethylphosphonate, Polyurethane Foam-Forming Compositions, Polyurethane Foam and Articles Made Therefrom STOWELL JEFFREY K 2011-10-20 US claimed
EP-2376507-A1 METHOD OF MAKING HYDROXYMETHYLPHOSPHONATE, POLYURETHANE FOAM-FORMING COMPOSITIONS POLYURETHANE FOAM AND ARTICLES MADE THEREFORM ICL-IP America Inc. (US) 2011-10-19 EP claimed
WO-2010080425-A1 METHOD OF MAKING HYDROXYMETHYLPHOSPHONATE, POLYURETHANE FOAM-FORMING COMPOSITIONS POLYURETHANE FOAM AND ARTICLES MADE THEREFORM SUPRESTA LLC. (US) 2010-07-15 WO claimed
US-20100160468-A1 Method of making hydroxymethylphosphonate, polyurethane foam-forming compositions, polyurethane foam and articles made therefrom ICL-IP AMERICA INC. 2010-06-24 US claimed
CN-116606212-B Method for economically and continuously preparing tertiary amine 浙江新化化工股份有限公司 2025-05-09 CN disclosed
CN-118684667-A Compounds for the treatment of fasciolopsis 默克专利股份有限公司 2024-09-24 CN disclosed
US-12077631-B2 Bulk polymerisation of polyoxazolidone BASF SE (DE) 2024-09-03 US disclosed
CN-112512636-B Compounds for the treatment of fasciolopsis 默克专利股份有限公司 2024-06-18 CN disclosed
US-20070269309-A1 Method for Operating a Liquid Ring Compressor BASF AKTIENGESELLSCHAFT (DE) 2007-11-22 US disclosed
US-20070095645-A1 Distillation of ionic liquids BASF AKTIENGESELLSCHAFT (DE) 2007-05-03 US disclosed
US-20050020857-A1 Removal by salt formation BASF AKTIENGESELLSCHAFT (DE) 2005-01-27 US disclosed
EP-0404619-B1 PROCESS FOR THE PRODUCTION OF N-MONOALKYL OR ALKENYL ANILINES RHONE-POULENC CHIMIE (FR) 1993-09-29 EP disclosed
EP-0404619-A1 Process for the production of n-monoalkyl or alkenyl anilines RHONE-POULENC CHIMIE (FR) 1990-12-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110257287-A1 Method of Making Hydroxymethylphosphonate, Polyurethane Foam-Forming Compositions, Polyurethane Foam and Articles Made Therefrom PFAS, PGM2, NEFM GABRR1 3836/4885GABBR2 1548/4885GABBR1 2054/4885
US-20100160468-A1 Method of making hydroxymethylphosphonate, polyurethane foam-forming compositions, polyurethane foam and articles made therefrom PFAS, PGM2, NEFM GABRR1 3836/4885GABBR2 1548/4885GABBR1 2054/4885
US-20050020857-A1 Removal by salt formation PHOSPHO1, AASDHPPT, INPP5B GABRR1 4530/4885GABBR2 2512/4885GABBR1 3466/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.